Authors: Pagani, FD Dyke, DB Wright, S Cody, R Aaronson, KD

Citation: Fd. Pagani et al., Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: Effects on subsequent allograft rejection and survival, J HEART LUN, 20(6), 2001, pp. 646-653

Authors: Pagani, FD Aaronson, KD Swaniker, F Bartlett, RH

Citation: Fd. Pagani et al., The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device, ANN THORAC, 71(3), 2001, pp. S77-S81

Authors: Kolias, TJ Aaronson, KD Armstrong, WF

Citation: Tj. Kolias et al., Doppler-derived dP/dt and -dP/dt predict survival in congestive heart failure, J AM COL C, 36(5), 2000, pp. 1594-1599

Authors: Pagani, FD Aaronson, KD Dyke, DB Wright, S Swaniker, F Bartlett, RH

Citation: Fd. Pagani et al., Assessment of an extracorporeal life support to LVAD bridge to heart transplant strategy, ANN THORAC, 70(6), 2000, pp. 1977-1984

Authors: Aaronson, KD Mancini, DM

Citation: Kd. Aaronson et Dm. Mancini, Mortality remains high for outpatient transplant candidates with prolonged(> 6 months) waiting list time, J AM COL C, 33(5), 1999, pp. 1189-1195

Authors: Pagani, FD Lynch, W Swaniker, F Dyke, DB Bartlett, R Koelling, T Moscucci, M Deeb, GM Bolling, S Monaghan, H Aaronson, KD

Citation: Fd. Pagani et al., Extracorporeal life support to left ventricular assist device bridge to heart transplant - A strategy to optimize survival and resource utilization, CIRCULATION, 100(19), 1999, pp. 206-210